VOYA Investment Management
KNSA icon

VOYA Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

VOYA Investment Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,790
Closed -$239K – 2401
2025
Q4 		$239K Sell
5,790
-2,075
-26% -$83.2K ﹤0.01% 2079
2025
Q3 		$305K Sell
7,865
-12,191
-61% -$396K ﹤0.01% 1981
2025
Q2 		$555K Sell
20,056
-10,810
-35% -$275K ﹤0.01% 1846
2025
Q1 		$686K Buy
30,866
+10,878
+54% +$224K ﹤0.01% 1726
2024
Q4 		$395K Buy
19,988
+2,870
+17% +$65.5K ﹤0.01% 2049
2024
Q3 		$428K Buy
17,118
+4,344
+34% +$106K ﹤0.01% 2085
2024
Q2 		$238K Buy
12,774
+2,199
+21% +$41.2K ﹤0.01% 2380
2024
Q1 		$209K Sell
10,575
-2,183
-17% -$42.6K ﹤0.01% 2432
2023
Q4 		$224K Sell
12,758
-372
-3% -$6.11K ﹤0.01% 2526
2023
Q3 		$228K Hold
13,130
– – ﹤0.01% 2472
2023
Q2 		$185K Buy
13,130
+289
+2% +$3.87K ﹤0.01% 2618
2023
Q1 		$138K Sell
12,841
-8,600
-40% -$113K ﹤0.01% 2642
2022
Q4 		$321K Sell
21,441
-2,609
-11% -$38K ﹤0.01% 2290
2022
Q3 		$309K Buy
24,050
+12,122
+102% +$138K ﹤0.01% 2328
2022
Q2 		$116K Hold
11,928
– – ﹤0.01% 2579
2022
Q1 		$119K Hold
11,928
– – ﹤0.01% 2489
2021
Q4 		$140K Buy
11,928
+100
+0.8% +$1.23K ﹤0.01% 2606
2021
Q3 		$135K Hold
11,828
– – ﹤0.01% 2673
2021
Q2 		$165K Sell
11,828
-136
-1% -$2.07K ﹤0.01% 2658
2021
Q1 		$221K Buy
11,964
+581
+5% +$11.9K ﹤0.01% 2487
2020
Q4 		$201K Buy
+11,383
New +$200K ﹤0.01% 2423

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VOYA Investment Management's KNSA Position: Q1 2026 in Review

VOYA Investment Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2026, closing a stake of 5,790 shares — an estimated $239K sold.

VOYA Investment Management first reported a position in KNSA in Q4 2020 and held it in 21 quarters. The position peaked at $686K in Q1 2025. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • VOYA Investment Management reported no remaining Kiniksa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • VOYA Investment Management sold 5,790 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $239K.
  • VOYA Investment Management first reported a position in Kiniksa Pharmaceuticals in Q4 2020 and held it in 21 quarters.
  • VOYA Investment Management's Kiniksa Pharmaceuticals position peaked at $686K in Q1 2025.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.